Department of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.
J Infect Dis. 2011 May 15;203(10):1425-33. doi: 10.1093/infdis/jir049. Epub 2011 Mar 16.
Viral load may influence the course of human papillomavirus type 16 (HPV-16) infection.
This case-control study was nested within the 2-year Atypical Squamous Cells of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study, in which women were followed semiannually for HPV and cervical intraepithelial neoplasia (CIN). Case patients (n = 62) were women diagnosed with CIN3 following HPV-16-positive detection at a follow-up visit. HPV-16-positive controls (n = 152) without CIN2 or CIN3 were matched to cases based on the follow-up visit in which viral load was measured. Real-time polymerase chain reaction was used for HPV-16 DNA quantification.
The risk of CIN3 increased with increasing HPV-16 DNA load at the follow-up visit (odds ratio, 1.63; 95% confidence interval, 1.33-1.99 per 1 log(10) unit increase); the association was not affected by whether HPV-16 was present at enrollment. When HPV-16 was present at both enrollment and follow-up, viral load remained high among cases (P = .77) but decreased substantially among controls (P = .004). Among women with HPV-16 found initially during follow-up, viral load in the first HPV-16-positive sample was associated with short-term persistence; load was higher in those with infection, compared with those without infection, 1 visit after the initial positivity (P = .001).
Viral load of newly detected infections and changes in viral load predict persistence and progression of HPV-16 infections.
病毒载量可能会影响人乳头瘤病毒 16 型(HPV-16)感染的进程。
本病例对照研究嵌套于为期 2 年的非典型意义不明确的鳞状细胞和低级别鳞状上皮内病变分流研究中,该研究中女性每半年接受一次 HPV 和宫颈上皮内瘤变(CIN)随访。病例患者(n=62)为在随访时 HPV-16 阳性检测后诊断为 CIN3 的女性。HPV-16 阳性对照(n=152)无 CIN2 或 CIN3,与病例根据测量病毒载量的随访时间相匹配。采用实时聚合酶链反应进行 HPV-16 DNA 定量。
随访时 HPV-16 DNA 载量增加与 CIN3 的风险增加相关(比值比,1.63;95%置信区间,1.33-1.99,每增加 1 个 log10 单位);该关联不受 HPV-16 是在入组时存在还是在随访时存在的影响。当 HPV-16 既在入组时存在又在随访时存在时,病例中病毒载量仍保持较高水平(P=.77),但在对照组中病毒载量显著降低(P=.004)。在最初随访期间发现 HPV-16 的女性中,第一个 HPV-16 阳性样本中的病毒载量与短期持续性相关;与无感染相比,在感染女性中,在最初阳性后 1 次就诊时病毒载量更高(P=.001)。
新发现感染的病毒载量和病毒载量的变化可预测 HPV-16 感染的持续性和进展。